scispace - formally typeset
M

Melyssa Aronson

Researcher at Mount Sinai Hospital, Toronto

Publications -  122
Citations -  6962

Melyssa Aronson is an academic researcher from Mount Sinai Hospital, Toronto. The author has contributed to research in topics: Lynch syndrome & Cancer. The author has an hindex of 32, co-authored 100 publications receiving 5889 citations. Previous affiliations of Melyssa Aronson include Hospital for Sick Children & Mount Sinai Hospital.

Papers
More filters
Journal ArticleDOI

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer.

TL;DR: High-frequency microsatellite instability in colorectal cancer is independently predictive of a relatively favorable outcome and, in addition, reduces the likelihood of metastases.
Journal ArticleDOI

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency

TL;DR: This report of initial and durable responses of recurrent GBM to immune checkpoint inhibition may have implications for GBM in general and other hypermutant cancers arising from primary (genetic predisposition) or secondary MMRD.
Journal ArticleDOI

Comprehensive Analysis of Hypermutation in Human Cancer

Brittany Campbell, +63 more
- 16 Nov 2017 - 
TL;DR: An extensive assessment of mutation burden through sequencing analysis of >81,000 tumors from pediatric and adult patients, including tumors with hypermutation caused by chemotherapy, carcinogens, or germline alterations, uncovered new driver mutations in the replication-repair-associated DNA polymerases and a distinct impact of microsatellite instability and replication repair deficiency on the scale of mutation load.
Journal ArticleDOI

Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers

TL;DR: Estimates of both absolute and relative cancer risks for MSH6 mutation carriers are obtained, which are precise and accurate.